A 52-year-old man with known type 2 diabetes for 8 years presents with progressive fatigue and dyspnea. His HbA1c is 8.2%. Serum creatinine is 2.8 mg/dL (eGFR 22 mL/min/1.73 m²). Which investigation is most appropriate to assess the structural renal pathology and guide prognosis in diabetic nephropathy?

## Diagnostic Confirmation of Diabetic Nephropathy Pathology **Key Point:** Kidney biopsy with light microscopy and immunofluorescence is the gold standard for definitive diagnosis and pathological staging of diabetic nephropathy. It directly visualizes nodular glomerulosclerosis (Kimmelstiel-Wilson lesions) and allows assessment of disease stage, reversibility, and prognosis. ### When Kidney Biopsy is Indicated in Diabetes | Scenario | Indication for Biopsy | |---|---| | **Typical diabetic nephropathy** (proteinuria + declining GFR + no hematuria) | Usually NOT needed; diagnosis clinical | | **Atypical presentation** (hematuria, RBC casts, rapid GFR decline, absence of retinopathy) | **YES** — to exclude other glomerulonephritis | | **Advanced CKD (Stage 4–5)** with need for prognostic information | **YES** — to assess reversibility and guide intensity of therapy | | **Research or prognostic stratification** | **YES** — to identify Kimmelstiel-Wilson lesions and stage fibrosis | ### Histopathological Features Seen on Biopsy 1. **Light microscopy:** - Nodular glomerulosclerosis (Kimmelstiel-Wilson lesions) — pathognomonic - Diffuse glomerulosclerosis - Basement membrane thickening - Hyaline arteriolosclerosis 2. **Immunofluorescence:** - Linear IgG and IgM deposits along glomerular basement membrane - Absence of immune complex deposits (distinguishes from post-infectious GN) ### Staging of Diabetic Nephropathy (Tervaert Classification) | Stage | Histology | |---|---| | **Stage 1** | Glomerular basement membrane thickening; no nodules | | **Stage 2a** | Nodular lesions; <50% of glomeruli affected | | **Stage 2b** | Nodular lesions; ≥50% of glomeruli affected | | **Stage 3** | Advanced nodular sclerosis with >50% global sclerosis | | **Stage 4** | Advanced diabetic changes + additional FSGS or membranoproliferative pattern | **High-Yield:** Biopsy is essential when clinical presentation is **atypical** (hematuria, RBC casts, rapid GFR decline, absence of diabetic retinopathy) to exclude superimposed non-diabetic glomerulonephritis. **Clinical Pearl:** In this case, the patient has CKD Stage 3b with 8 years of diabetes. If retinopathy is absent or hematuria is present, biopsy should be strongly considered to exclude alternative diagnoses and assess reversibility before progression to ESRD. [cite:Harrison 21e Ch 279; Robbins 10e Ch 20]